Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM)

CUSIP: 230031106

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
59,091,689
Total 13F shares
31,323,171
Share change
+31,323,171
Total reported value
$1,298,948,827
Price per share
$41.67
Number of holders
70
Value change
+$1,298,948,827
Number of buys
70

Quarterly Holders Quick Answers

What is CUSIP 230031106?
CUSIP 230031106 identifies CGEM - Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM) as of Q1 2021

As of 31 Mar 2021, Cullinan Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CGEM) was held by 70 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,323,171 shares. The largest 10 holders included MPM Oncology Impact Management LP, Foresite Capital Management V, LLC, CHI Advisors LLC, BAUPOST GROUP LLC/MA, FMR LLC, EVENTIDE ASSET MANAGEMENT, LLC, VR Adviser, LLC, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, and Rock Springs Capital Management LP. This page lists 70 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.